Your trusted destination for CME, CPD & Medical Education across the Middle East.
The Global Respiratory Health Summit 2026 is a two-day hybrid medical summit taking place on 17–18 November 2026 in Dubai, UAE, with Day 1 held in person and Day 2 delivered virtually. The summit focuses on advancing respiratory medicine across MENA and beyond, bringing together clinicians, researchers, policymakers, and healthcare innovators to address major respiratory diseases and emerging challenges.
The summit provides a multidisciplinary platform covering the full spectrum of respiratory health, including COPD, asthma, pulmonary fibrosis, lung cancer, tuberculosis, Long COVID, respiratory infections, and occupational and environmental lung disease. Key sessions will explore innovations in respiratory diagnostics and therapeutics, including AI-assisted diagnosis, digital health, precision medicine, biomarkers, biologics, smart inhalers, and remote patient monitoring. The programme also addresses public-health priorities such as air pollution, climate change, antimicrobial resistance, vaccination, TB control, and equitable access to respiratory care. Sessions on chronic respiratory disease management will highlight COPD, severe asthma, interstitial lung disease, pulmonary rehabilitation, Long COVID, and patient-centred care. The summit also features oral and poster research presentations, networking opportunities, an exhibition, and an industry innovation showcase. Confirmed speakers include respiratory and infectious-disease specialists from institutions in the UAE, with additional speakers being announced on a rolling basis.
Exploring AI in respiratory diagnosis and remote patient monitoring technologies.
Utilizing biomarker-guided therapy and personalized approaches in respiratory care.
Advancements in biologics, drug delivery innovations, and smart inhaler technology.
Addressing the environmental impact on global respiratory disease burden.
Strategies for managing Tuberculosis, drug resistance, pneumonia, and emerging infections.
Improving vaccination strategies and ensuring equitable access to respiratory care globally.
Advancing personalized care, biologic therapies, and management protocols for chronic conditions.
Diagnostic and therapeutic approaches for pulmonary fibrosis and complex lung diseases.
Managing chronic respiratory symptoms post-COVID and implementing effective pulmonary rehabilitation.
Integrating AI-enabled healthcare systems and digital therapeutics into clinical practice.
Global strategies and precision public health initiatives for future respiratory pandemics.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow